TY - BOOK ID - 32940668 TI - Resistance to Ibritumomab in Lymphoma AU - Hosono, Makoto. AU - Chatal, Jean-François. PY - 2018 SN - 331978238X 3319782371 PB - Cham : Springer International Publishing : Imprint: Springer, DB - UniCat KW - Lymphomas KW - Drug resistance in cancer cells. KW - Treatment. KW - Medicine. KW - Cancer research. KW - Biomedicine. KW - Cancer Research. KW - Cancer research KW - Clinical sciences KW - Medical profession KW - Human biology KW - Life sciences KW - Medical sciences KW - Pathology KW - Physicians KW - Antitumor drug resistance KW - Cancer drug resistance KW - Drug resistance in cancer KW - Drug resistance in tumor cells KW - Cancer cells KW - Germinoblastomas KW - Immunoblastomas KW - Lymphoma KW - Non-Hodgkin's lymphoma KW - Reticulolymphosarcomas KW - Sarcoma, Germinoblastic KW - Sarcoma, Immunoblastic KW - Lymphoproliferative disorders KW - Reticulo-endothelial system KW - Tumors KW - Oncology. UR - https://www.unicat.be/uniCat?func=search&query=sysid:32940668 AB - This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab. ER -